'For me, it didn't seem as drastic a step as being controlled by insulin': A qualitative investigation of expectations and experiences of non-insulin injectable therapy among adults with type 2 diabetes
Elizabeth Holmes-Truscott, Jasmine Schipp, Trisha Dunning, John Furler, Virginia Hagger, Edith E Holloway, Jo-Anne Manski-Nankervis, Jonathan E Shaw, Timothy Skinner, Jane Speight
DIABETIC MEDICINE | WILEY | Published : 2021
AIMS: This qualitative study aims to explore beliefs, attitudes and experiences of injectable glucagon-like-peptide-1 receptor agonists (GLP-1RAs) use and discontinuation, as well as attitudes to further injectable treatment intensification, among adults with type 2 diabetes (T2D). METHODS: Nineteen in-depth semi-structured interviews lasting (mean ± standard deviation) 45 ± 18 min were conducted, face-to-face (n = 14) or via telephone (n = 5). Transcripts were analysed using inductive template analyses. Eligible participants were English-speaking adults with T2D who had recently initiated (≤3 years) GLP-1RA treatment. RESULTS: Participants were aged 28-72 years, who predominantly lived in m..View full abstract
Direct research costs and Elizabeth Holmes-Truscott were funded by a Deakin University Deans Research Postdoctoral Fellowship (2018-2020). Jane Speight, Jasmine Schipp and Elizabeth Holmes-Truscott (in part) were supported by the core funding to the Australian Centre for Behaviour Research in Diabetes (ACBRD) provided by the collaboration between Diabetes Victoria and Deakin University. Timothy Skinner is funded by the Multi-Disciplinary Health Training program, Department of Health, Commonwealth Government of Australia.